Currently, 7 API plants are running at Kyongbo site. Kyongbo has accumulated intensive expertise and
experience in API processes required to fulfill CRMO projects from pre-clinical up to Clinical trials phase Ⅰ,Ⅱ,Ⅲ.
Skilled staffs with sufficient experiences from CRMO Business Unit (CBU) in Kyongbo are set up to focus
on the project and expand the business abroad which will facilitate the close communication and speedy
response with the clients.
Wide range of manufacturing facilities and analytical instruments (NMR, XRD, FT-IR, UV-Vis, LC (GC)-mass,
ICP, DSC, TGA, PSD, SEM, Electron Microscope, and etc) are available so we are capable of developing the
process, identification & isolation of impurities.